Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0000905718-19-000108

Options or other derivatives

  • Chief Scientific Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MANNINO RAPHAEL J · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-02-11 Grant or award : show line 1 in the form Stock option (right to buy) +150,000 150,000 D
Loading xslF345X03/mannino-matinasfm4_feb112019.xml…